Inpeco

Executive Summary

Inpeco is a Swiss medical technology company specializing in total laboratory automation (TLA) for the in-vitro diagnostics (IVD) market. Since its founding in 1990, the company has focused on automating pre-analytical and post-analytical sample processing steps such as sorting, centrifugation, decapping, and storage. Its systems integrate with multiple analytical instruments from different manufacturers, creating seamless, traceable workflows that improve laboratory efficiency and data integrity. Inpeco's solutions are used by clinical laboratories worldwide, addressing the increasing demand for higher throughput and reduced manual intervention. The global IVD automation market is expanding due to lab consolidation, rising test volumes, and the need for error reduction. Inpeco is well-positioned with a strong patent portfolio and a reputation for reliability. As a private company with no disclosed financials, its growth trajectory is less visible, but its established customer base and continuous innovation suggest steady performance. Key opportunities include expanding in emerging markets, launching next-generation systems, and forming strategic partnerships with diagnostic instrument makers.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation TLA System70% success
• Q2 2026Expansion into Asia-Pacific via Distribution Partnerships60% success
• TBDStrategic Acquisition of a Complementary Diagnostics Company40% success